The Anesthetic Management of the First Lung Transplant for a Patient with COVID-19 Respiratory Failure
THE NOVEL coronavirus was first detected in China at the end of 2019, and there were 3,517,345 confirmed coronavirus disease 2019 (COVID-19) cases and 243,401 deaths worldwide as of May 5, 2020, including in United States.1-3 According to Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7),4 pathologic findings from limited autopsies and biopsy studies indicate variable consolidations are present in the lungs, and organization of alveolar exudates and interstitial fibrosis also are present.
Source: Journal of Cardiothoracic and Vascular Anesthesia - Category: Anesthesiology Authors: Chunxiao Hu, Guilong Wang, Difei Zhou, Wei Wang, Zhong Qin, Yanjuan Wang, Jingyu Chen, Hong Liu, Quan Li, Dongxiao Huang Tags: Case Report Source Type: research
More News: Anesthesia | Anesthesiology | Cardiology | China Health | Coronavirus | COVID-19 | Heart | Lung Transplant | Pneumonia | Respiratory Medicine | Study | Transplant Surgery | Transplants | USA Health